Pre-market hot trades in US stocks: WF pre-market down 7.11%; MACOM Technology Solutions Holdings pre-market up 7.02%

Pre-market Hot Trades in US Stocks

WF, down 7.11% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

MACOM Technology Solutions Holdings is up 7.02% in pre-market. Based on recent news,

1. On July 11, MACOM Technology Solutions Holdings announced a partnership with global giants General Motors and POSCO to promote the application of its patented technology. This technology can recover three times more lithium than traditional methods, with market demand for lithium expected to grow fivefold by 2040. This news sparked strong interest from investors, driving the stock price up.

2. On July 10, MACOM Technology Solutions Holdings released its latest quarterly financial report, showing that both its revenue and profit exceeded market expectations. Strong financial performance boosted market confidence, further driving the stock price up.

3. On July 9, analysts generally raised their ratings for MACOM Technology Solutions Holdings, believing that its leading position in the data center chip market will bring sustained growth. Analysts' optimistic expectations attracted more investors to buy, pushing the stock price up. The demand in the data center chip market is strong, driving related companies' stock prices up.

Top Gainers in Pre-market US Stocks

NextCure is up 320.15% in pre-market. Based on recent news,

1. On July 14, NextCure announced it will merge with Avere Therapeutics and will operate under the name Avere Therapeutics. This news significantly boosted NextCure's stock price by 93%.

2. On July 14, NextCure announced it secured $320 million in private financing to develop AVR-001, an experimental weekly drug for inflammatory diseases. This financing news further boosted market confidence.

3. On July 14, NextCure's shareholders will be entitled to 98.8% of the merged company's shares, while NextCure shareholders will only hold 1.2%. This news triggered a positive market reaction, leading to a significant increase in stock price. The biotechnology sector has been active recently, with noticeable capital inflows.

Shuttle Pharmaceuticals is up 54.39% in pre-market. Based on recent key news:

1. On July 13, HRT Financial LP increased its direct holdings in Shuttle Pharmaceuticals, purchasing 8,997 shares at prices between $3.11 and $3.38. This move indicates increased market confidence in the company, driving the stock price up. Source: EDGAR system disclosure.

2. On July 13, HRT Financial reported a 10% stake in Shuttle Pharmaceuticals in Form 3, showing it held 60,540 shares as of July 9 The disclosure of this shareholding information further supports the rise in stock prices. Source: The EDGAR system reveals an increased market interest in biotech stocks, with significant capital inflows.

Linkhome, up 42.20% in pre-market trading, has had no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation